Celladon | Evaluate

Therapy focus – Strimvelis approval could rejuvenate gene therapy arena

January 07, 2016

Wobbles aside, small pharma shares broadly on the up in 2015

November 03, 2015

Therapy focus – Entresto Effect drives heart failure activity

October 06, 2015

Among smaller biopharmas, US groups take a back seat

October 06, 2015

Spark stumbles into gene therapy landmark

July 08, 2015

Entresto approval revives heart failure sector

July 03, 2015

Sector’s smaller players show the way

June 26, 2015

Upcoming events: UniQure looks to prove gene therapy and crunch time for Tetraphase’s lead antibiotic

June 15, 2015

Why dealmakers should look to Servier

April 30, 2015

Gene therapy investors should keep eye out for ophthalmic data

April 27, 2015

Celladon spoils the gene therapy party

Load More